Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 20.574mg equivalent to atomoxetine 18mg - capsule - 18 mg - active: atomoxetine hydrochloride 20.574mg equivalent to atomoxetine 18mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide yellow magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 28.575mg equivalent to atomoxetine 25mg - capsule - 25 mg - active: atomoxetine hydrochloride 28.575mg equivalent to atomoxetine 25mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 45.72mg equivalent to atomoxetine 40mg - capsule - 40 mg - active: atomoxetine hydrochloride 45.72mg equivalent to atomoxetine 40mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine   magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 5.715mg equivalent to atomoxetine 5mg - capsule - 5 mg - active: atomoxetine hydrochloride 5.715mg equivalent to atomoxetine 5mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide yellow   magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 68.58mg equivalent to atomoxetine 60mg - capsule - 60 mg - active: atomoxetine hydrochloride 68.58mg equivalent to atomoxetine 60mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   indigo carmine iron oxide yellow magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

arrotex pharmaceuticals (nz) limited - atomoxetine hydrochloride 91.44mg equivalent to atomoxetine 80mg - capsule - 80 mg - active: atomoxetine hydrochloride 91.44mg equivalent to atomoxetine 80mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin   iron oxide black iron oxide red iron oxide yellow magnesium stearate opacode black s-1-277002 starch titanium dioxide   - treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

Malta - angļu - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 20 mg - psychoanaleptics

Malta - angļu - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - duloxetine hydrochloride - gastro-resistant hard capsule - duloxetine hydrochloride 40 mg - psychoanaleptics

Malta - angļu - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - alendronic acid, colecalciferol - tablet - alendronic acid 70 mg colecalciferol 140 µg - drugs for treatment of bone diseases

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - esomeprazole magnesium dihydrate, quantity: 21.69 mg - capsule, enteric - excipient ingredients: polysorbate 20; triethyl citrate; mannitol; diacetylated monoglycerides; purified water; sodium benzoate; polysorbate 80; titanium dioxide; sucrose; propylene glycol; sorbic acid; maize starch; octoxinol; dimeticone 350; propyl hydroxybenzoate; purified talc; stearoyl macrogolglycerides; gelatin; hypromellose; methyl hydroxybenzoate; iron oxide yellow; methacrylic acid - ethyl acrylate copolymer (1:1); ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pharmacy choice esomeprazole heartburn relief is indicated for the symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux disease (gord).